Endogenous Aminopeptidase N Decreases the Potency of Peptide Agonists and Antagonists of the Kinin B1 Receptors in the Rabbit Aorta

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Journal of Pharmacology and Experimental Therapeutics

• Publication date

  2005-09-01

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1124/JPET.105.088799PMID 15919764
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Potentiation of des-Arg 9 -Kallidin-Induced Vasoconstrictor Responses by Metallopeptidase Inhibition in Isolated Human Umbilical Artery

  2005cited by this paper
• Potentiation of des-Arg9-Kallidin-Induced Vasoconstrictor Responses by Metallopeptidase Inhibition in Isolated Human Umbilical Artery

  2005cited by this paper
• International Union of Pharmacology. XLV. Classification of the Kinin Receptor Family: from Molecular Mechanisms to Pathophysiological Consequences

  2005cited by this paper
• Pharmacological characterization and radioligand binding properties of a high-affinity, nonpeptide, bradykinin B1 receptor antagonist.

  2004cited by this paper
• A Novel Nonpeptide Antagonist of the Kinin B1 Receptor: Effects at the Rabbit Receptor

  2004cited by this paper
• Role of Bradykinin B2 and B1 Receptors in the Local, Remote, and Systemic Inflammatory Responses That Follow Intestinal Ischemia and Reperfusion Injury1

  2004cited by this paper
• Ontogenic and adult whole body distribution of aminopeptidase N in rat investigated by in vitro autoradiography.

  2004cited by this paper
• The role of ACE2 in cardiovascular physiology.

  2003cited by this paper
• Biological significance of aminopeptidase N/CD13 in thyroid carcinomas.

  2003cited by this paper
• Demonstration of puromycin-sensitive alanyl aminopeptidase in Alzheimer disease brain.

  2003cited by this paper
• Do angiotensin-converting enzyme inhibitors directly stimulate the kinin B1 receptor?

  2003cited by this paper
• International Union of Pharmacology: Approaches to the Nomenclature of Voltage-Gated Ion Channels

  2003cited by this paper
• Angiotensin-Converting Enzyme Inhibitor-Associated Angioedema Is Characterized by a Slower Degradation of des-Arginine 9 -Bradykinin

  2002cited by this paper
• Induction of Functional Bradykinin B1-Receptors in Normotensive Rats and Mice Under Chronic Angiotensin-Converting Enzyme Inhibitor Treatment

  2002cited by this paper
• Bradykinin B1 receptor blocks PDGF-induced mitogenesis by prolonging ERK activation and increasing p27Kip1.

  2002cited by this paper
• Agonist-induced translocation of the kinin B(1) receptor to caveolae-related rafts.

  2002cited by this paper
• Angiotensin-Converting Enzyme Inhibitor-Associated Angioedema Is Characterized by a Slower Degradation of des-Arginine9-Bradykinin

  2002cited by this paper
• Targeting Kinin B1 Receptor for Therapeutic Neovascularization

  2002cited by this paper
• Differential binding of drugs containing the NGR motif to CD13 isoforms in tumor vessels, epithelia, and myeloid cells.

  2002cited by this paper
• Expression of kinin B1 receptor in fresh or cultured rabbit aortic smooth muscle: role of NF-κB

  2002cited by this paper
• Up-Regulation of Functional Kinin B1 Receptors in Allergic Airway Inflammation1

  2002cited by this paper
• Detrimental implication of B1 receptors in myocardial ischemia: evidence from pharmacological blockade and gene knockout mice.

  2002cited by this paper
• Bradykinin B 1 receptor blocks PDGF-induced mitogenesis by prolonging ERK activation and increasing p 27 Kip 1

  2002cited by this paper
• Endotoxin sensitization to kinin B1 receptor agonist in a non‐human primate model: haemodynamic and pro‐inflammatory effects

  2001cited by this paper
• Endothelial kinin B1‐receptors are induced by myocardial ischaemia‐reperfusion in the rabbit

  2001cited by this paper
• Non‐competitive pharmacological antagonism at the rabbit B1 receptor

  2000cited by this paper
• Bradykinin B1 Receptor Mediates Inhibition of Neointima Formation in Rat Artery After Balloon Angioplasty

  2000cited by this paper
• Bradykinin B(1) receptor-mediated changes in renal hemodynamics during endotoxin-induced inflammation.

  2000cited by this paper
• Bradykinin B(1) receptor mediates inhibition of neointima formation in rat artery after balloon angioplasty.

  2000cited by this paper
• Inducible expression of the kinin B1 receptor in the endotoxemic heart: mechanisms of des‐Arg9bradykinin‐induced coronary vasodilation

  1999cited by this paper
• Kallidin- and bradykinin-degrading pathways in human heart: degradation of kallidin by aminopeptidase M-like activity and bradykinin by neutral endopeptidase.

  1999cited by this paper
• CD13—not just a marker in leukemia typing

  1999influential reference
• The B1 receptors for kinins.

  1998cited by this paper
• Kinin receptors in human vascular tissue: their role in atheromatous disease.

  1997cited by this paper
• Cardiovascular effects of Sar-[D-Phe8]des-Arg9-bradykinin, a metabolically protected agonist of B1 receptor for kinins, in the anesthetized rabbit pretreated with a sublethal dose of bacterial lipopolysaccharide.

  1997cited by this paper
• Induction of the membrane alanyl aminopeptidase gene and surface expression in human T-cells by mitogenic activation.

  1996cited by this paper
• Pharmacological analysis of drug-receptor interaction: Kenakin, T., 2nd Edn, XII + 483 pp. New York: Raven Press (1993)

  1994cited by this paper
• Development and in vivo evaluation of metabolically resistant antagonists of B1 receptors for kinins.

  1993cited by this paper
• Metabolism of bradykinin analogs by angiotensin I converting enzyme and carboxypeptidase N.

  1991cited by this paper
• Hypotensive effects of Lys-des-Arg9-bradykinin and metabolically protected agonists of B1 receptors for kinins.

  1991cited by this paper
• Metabolism of vasoactive peptides by vascular endothelium and smooth muscle aminopeptidase M.

  1989cited by this paper
• Metabolism of bradykinin by multiple coexisting membrane-bound peptidases in lung: techniques for investigating the role of each peptidase using specific inhibitors.

  1989cited by this paper
• Major localization of aminopeptidase M in rat brain microvessels.

  1987cited by this paper
• Vascular, plasma membrane aminopeptidase M. Metabolism of vasoactive peptides.

  1985cited by this paper
• Manual of pharmacologic calculations with computer programs

  1982cited by this paper

• Picomolar Sensitivity Analysis of Multiple Bradykinin-Related Peptides in the Blood Plasma of Patients With Hereditary Angioedema in Remission: A Pilot Study

  2022cites this paper
• CD13/Aminopeptidase N Is a Potential Therapeutic Target for Inflammatory Disorders

  2020cites this paper
• Bifunctional ligands of the bradykinin B2 and B1 receptors: An exercise in peptide hormone plasticity.

  2018cites this paper
• Local Angiotensin Pathways in Human Carotid Atheroma: Towards a Systems Biology Approach

  2015cites this paper
• N-terminal extended conjugates of the agonists and antagonists of both bradykinin receptor subtypes: structure-activity relationship, cell imaging using ligands conjugated with fluorophores and prospect for functionally active cargoes.

  2012cites this paper
• Cooperative effects of aminopeptidase N (CD13) expressed by nonmalignant and cancer cells within the tumor microenvironment

  2012cites this paper
• Microarray‐based identification of aminopeptidase N target genes in keratinocyte conditioned medium‐stimulated dermal fibroblasts

  2012cites this paper
• LYP, a novel bestatin derivative, inhibits cell growth and suppresses APN/CD13 activity in human ovarian carcinoma cells more potently than bestatin

  2011cites this paper
• Met-Lys-bradykinin-Ser-Ser, a peptide produced by the neutrophil from kininogen, is metabolically activated by angiotensin converting enzyme in vascular tissue.

  2011cites this paper
• Amino-benzosuberone: a novel warhead for selective inhibition of human aminopeptidase-N/CD13.

  2011cites this paper
• Role of kinins in mediating vascular function in healthy pregnancy and pre-eclampsia

  2010cites this paper
• A ligand-based approach to investigate the expression and function of angiotensin converting enzyme in intact human umbilical vein endothelial cells.

  2010cites this paper
• Vascular smooth muscle contractility assays for inflammatory and immunological mediators.

  2010cites this paper
• Fluorescent Ligands of the Bradykinin B1 Receptors: Pharmacologic Characterization and Application to the Study of Agonist-Induced Receptor Translocation and Cell Surface Receptor Expression

  2009cites this paper
• The moonlighting enzyme CD13: old and new functions to target

  2008cites this paper
• B-9972 (D-Arg-[Hyp3,Igl5,Oic7,Igl8]-bradykinin) Is an Inactivation-Resistant Agonist of the Bradykinin B2 Receptor Derived from the Peptide Antagonist B-9430 (D-Arg-[Hyp3,Igl5,D-Igl7,Oic8]-bradykinin): Pharmacologic Profile and Effective Induction of Receptor Degradation

  2007cites this paper
• Neutral Endopeptidase Up-Regulation in Isolated Human Umbilical Artery: Involvement in Desensitization of Bradykinin-Induced Vasoconstrictor Effects

  2007cites this paper
• Functional evidence of des-Arg10-kallidin enzymatic inactivating pathway in isolated human umbilical vein

  2007influential citation
• Inactivation-Resistant Agonist of the Bradykinin B 2 Receptor Derived from the Peptide Antagonist B-9430 (D-Arg-(Hyp 3 ,Igl 5 ,D-Igl 7 ,Oic 8 )-bradykinin): Pharmacologic Profile and Effective Induction of Receptor Degradation

  2007cites this paper
• Discovery of a Dual-Function Peptide That Combines Aminopeptidase N Inhibition and Kinin B1 Receptor Antagonism

  2006cites this paper
• A Nonpeptide Antagonist Reveals a Highly Glycosylated State of the Rabbit Kinin B1 Receptor

  2006cites this paper
• Molecular identification and pharmacological profile of the bovine kinin B1 receptor

  2006cites this paper
• Advances in the development of bradykinin receptor ligands.

  2006cites this paper
• Dual antagonists of the bradykinin B1 and B2 receptors based on a postulated common pharmacophore from existing non-peptide antagonists

  2006cites this paper
• Title: Neutral endopeptidase up-regulation in isolated human umbilical artery: involvement in desensitization of bradykinin-induced vasoconstrictor effects. Authors: Pelorosso,

  2006cites this paper
• The bradykinin B2 receptor antagonist icatibant (Hoe 140) blocks aminopeptidase N at micromolar concentrations: off-target alterations of signaling mediated by the bradykinin B1 and angiotensin receptors.

  2006cites this paper